Artrya Ltd (AYA)

Currency in AUD
2.13
+0.18(+9.23%)
Closed·
AYA Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
AYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.932.13
52 wk Range
0.252.25
Key Statistics
Bid/Ask
2.10 / 1.97
Prev. Close
1.95
Open
1.95
Day's Range
1.93-2.13
52 wk Range
0.25-2.25
Volume
774.85K
Average Volume (3m)
418.93K
1-Year Change
565.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AYA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Artrya Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Artrya Ltd Company Profile

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Artrya Ltd Earnings Call Summary for Q4/2024

  • Artrya's stock rose 8.75% post-earnings call; company trading below Fair Value per InvestingPro analysis
  • 2024 profit fell to $382,000 from $15M due to $27M write-off; revenue down to $39.1M from $42M
  • 2025 outlook: silver production 5.0-5.3M oz, 88-90% mill recovery, $25-30M exploration budget
  • CEO: 2024 was construction-focused, 2025 is ramp-up year; Boumadin discovery costs low at $0.1/oz silver
  • Challenges: profit decline, ore blending recovery, single $100M debt; potential open pit mining expansion
Last Updated: 28/03/2025, 15:12
Read Full Transcript

Compare AYA to Peers and Sector

Metrics to compare
AYA
Peers
Sector
Relationship
P/E Ratio
−15.3x−4.5x−0.5x
PEG Ratio
−86.59−0.040.00
Price/Book
11.8x1.9x2.6x
Price / LTM Sales
8,949.0x3.5x3.3x
Upside (Analyst Target)
63.4%59.1%38.9%
Fair Value Upside
Unlock21.3%5.4%Unlock

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
-0.09 / --
Revenue / Forecast
15.00K / --
EPS Revisions
Last 90 days

AYA Income Statement

People Also Watch

101.79
WTC
+2.01%
3.300
DRO
+0.92%
212.89
CSL
+0.09%
30.88
CDA
+3.49%

FAQ

What Stock Exchange Does Artrya Trade On?

Artrya is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Artrya?

The stock symbol for Artrya is "AYA."

What Is the Artrya Market Cap?

As of today, Artrya market cap is 250.57M.

What Is Artrya's Earnings Per Share (TTM)?

The Artrya EPS (TTM) is -0.18.

From a Technical Analysis Perspective, Is AYA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Artrya Stock Split?

Artrya has split 0 times.

How Many Employees Does Artrya Have?

Artrya has 0 employees.

What is the current trading status of Artrya (AYA)?

As of 30 Aug 2025, Artrya (AYA) is trading at a price of 2.13, with a previous close of 1.95. The stock has fluctuated within a day range of 1.93 to 2.13, while its 52-week range spans from 0.25 to 2.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.